{
    "Trade/Device Name(s)": [
        "Diagnostic Hybrids' D3 DFA Chlamydiae Culture Confirmation Kit"
    ],
    "Submitter Information": "Diagnostic Hybrids, Inc.",
    "510(k) Number": "K063675",
    "Predicate Device Reference 510(k) Number(s)": [
        "K864389"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LJP"
    ],
    "Summary Letter Date": "August 10, 2007",
    "Summary Letter Received Date": "August 13, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.3120"
    ],
    "Regulation Name(s)": [
        "Chlamydia serological reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Chlamydiae lipopolysaccharide (LPS)"
    ],
    "Specimen Type(s)": [
        "Inoculated cell cultures"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Fluorescence microscope"
    ],
    "Method(s)/Technology(ies)": [
        "Immunofluorescence assay",
        "Fluoresceinated monoclonal antibodies"
    ],
    "Methodologies": [
        "Qualitative detection",
        "Immunofluorescence"
    ],
    "Submission Type(s)": [
        "Kit",
        "Reagent",
        "Control Slides"
    ],
    "Document Summary": "FDA 510(k) summary for Diagnostic Hybrids' D3 DFA Chlamydiae Culture Confirmation Kit for immunofluorescent detection of Chlamydiae LPS in cell cultures.",
    "Indications for Use Summary": "Qualitative detection of Chlamydiae lipopolysaccharide (LPS) in inoculated cell cultures by immunofluorescence using fluoresceinated monoclonal antibodies; not established for direct patient specimens.",
    "fda_folder": "Microbiology"
}